NewsBite

Alzheimer's

September

The study found evidence of people falling behind on their debts five years before diagnosis.

Alzheimer’s takes a financial toll long before diagnosis

People who develop dementia often begin falling behind on bills years earlier, research shows.

  • Ben Casselman

August

Anthony Bailey is an 85 year old man whose wife Lurlene has Alzheimer’s pictured in their retirement village home.

The Australians who may soon pay more for aged care

Labor and the Coalition are drawing closer to an agreement on changes to aged care funding. This is what it would mean.

  • Lucy Dean

March

Taiwanese researchers provided the first population evidence for a causal link between herpes and Alzheimer’s.

How this virus may increase your risk of developing Alzheimer’s

Serious research is under way on whether treating this virus with antiviral medication could reduce the risk of Alzheimer’s.

  • Jill Margo

January

Eli Lilly’s new drug works by removing a toxic protein called amyloid from the brains of early Alzheimer’s patients.

Alzheimer’s blood test a revolution for over-50s

A blood test that detects Alzheimer’s 10-15 years before a patient shows symptoms could be used to screen all over-50s.

  • Joe Pinkstone

March 2023

“Music can open forgotten doors to your memory,” says Andrew Budson ot the Veterans Affairs Boston Healthcare System.

Why music causes memories to flood back

Music could be used as a therapy for dementia anxiety, stress and chronic pain, say researchers.

  • Marlene Cimons
Advertisement

December 2022

Mental health services need more investment.

Alzheimer’s drug may benefit some patients: new data

A clinical trial of an experimental Alzheimer’s drug suggests the treatment slowed cognitive decline but caused some patients to experience brain swelling.

  • Pam Belluck

November 2022

A scientist working on Alzheimer’s research at drugmaker Biogen’s headquarters in Cambridge, Massachusetts. Biogen is one of the companies behind the drug lecanemab.

Second patient dies during Alzheimer’s drug trial

Shares in Eisai and Biogen, the two companies developing the drug, plunged after a second death was potentially linked to the breakthrough treatment.

  • Naomi Kresge

October 2022

New research suggests nose picking could increase the risk for Alzheimer’s and dementia.

‘Scary’ evidence nose picking could increase risk of dementia

Australian researchers have shown that bacteria can travel through the nose and into the brain of mice, where it creates markers that are a telltale sign of Alzheimer’s disease.

  • Joanna Mather

September 2022

A scientist working on Alzheimer’s research at drugmaker Biogen’s headquarters in Cambridge, Massachusetts. Biogen is one of the companies behind the drug lecanemab.

Alzheimer’s progression slowed by drug in major trial

Eisai and partner Biogen say their drug has slowed the pace of cognitive decline in people with early disease by 27 per cent when compared with a placebo.

  • Robert Langreth

July 2022

says Baroness Greenfield.

This famous 71-year-old scientist could hold the key to Alzheimer’s

Baroness Susan Greenfield is busy drumming up funding for her fourth start-up, which aims to identify the ageing disease long before symptoms appear.

  • Julie Hare

June 2022

Professor Susan Greenfield is behind a breakthrough cure for Alzheimer’s disease.

Breakthrough Alzheimer’s cure aims for human trials

Susan Greenfield has been doing the rounds talking to investors and potential collaborators about her breakthrough Alzheimer’s technology.

  • Julie Hare

February 2022

According to Dementia Australia, more than half a million Australians are living with dementia or younger onset dementia.

The first steps to take when a person has dementia

The symptoms and diagnosis may be scary and overwhelming, but among the myriad questions is a raft of legal issues to consider.

  • Bina Brown

December 2021

The famous blue pill  may be good for the dynamics of  blood flow in the brain too.

Study suggests Viagra can help prevent Alzheimer’s disease

A cutting-edge study, using big data and AI, has produced promising new evidence that Viagra-type drugs may help to prevent Alzheimer’s disease.

  • Jill Margo

August 2021

Scientists have speculated that exercise might directly change the biochemical environment inside the brain, without involving muscles.

How exercise may keep your memory sharp

The study, which was in mice, found that a hormone produced by muscles during exercise can cross into the brain and enhance the health and function of neurons, improving thinking and memory.

  • Gretchen Reynolds

June 2021

Doctors are hopeful this new drug will prove effective not only in removing the brain markers of Alzheimer’s but in improving brain function.

New Alzheimer’s drug approved in US amid controversy

The world’s first drug to remove Alzheimer type plaques from the brain has been approved for use in the US but critics say there’s no conclusive proof this helps.

  • Jill Margo
Advertisement
The potential that the drug will generate billions of dollars in annual sales sent Biogen’s stock soaring, and boosted the shares of rival drugmakers working on similar therapies.

Biogen’s colossal risk on Alzheimer’s pays off

The pharmaceutical group poured years of effort into developing the therapy, called aducanumab, and was counting on it as its next big advance.

  • Updated
  • Robert Langreth
Cogstate’s operations cover a number of segments including clinical drug trials, issues surrounding sports-related concussion and the assessment of cognition, particularly diseases such as Alzheimer’s.

Myer family-backed Cogstate jumps 60pc on Alzheimer’s news

Cogstate shares jumped 60 per cent by midday because its brain health screening tests will benefit from the approval of the first every Alzheimer’s treatment drug in the United States.

  • Carrie LaFrenz
A scientist working at Biogen’s headquarters in Cambridge, Massachusetts.

Alzheimer’s drug approved in disease landmark

A controversial antibody therapy developed by Biogen was granted accelerated approval by the US Food and Drug Administration.

  • Robert Langreth

February 2021

Subtle changes in the way people use language can be a sign they have Alzheimer’s.

AI spots Alzheimer’s in writing tests

Years before it manifests obviously, cognitive decline can be detected through subtle changes in the way people use language.

  • Gina Kolata

October 2020

The aim is not to reverse Alzheimer’s, but to arrest it in the early stages of the disease, says Professor Götz, .

Treating dementia from the inside

A Queensland team is experimenting with a way to help Alzheimer's patients by opening the blood-brain barrier.

  • Jill Margo

Original URL: https://www.afr.com/topic/alzheimers-5ua